These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Venous thrombosis is not increased in younger women on genuine oestrogen postmenopausal hormonal replacement therapy: results from the Danish Osteoporosis Prevention Study (DOPS). Kristensen SR; Abrahamsen B; Madsen JS; Gram J; Rejnmark L; Rud B; Jespersen J Thromb Haemost; 2006 May; 95(5):915-6. PubMed ID: 16676096 [No Abstract] [Full Text] [Related]
44. Postmenopausal hormone replacement: are two hormones better than one? Wood H; Wang-Cheng R; Nattinger AB J Gen Intern Med; 1993 Aug; 8(8):451-8. PubMed ID: 8410413 [No Abstract] [Full Text] [Related]
45. Oestrogen replacement treatment and the risk of endometrial cancer: an assessment of the role of covariates. Levi F; La Vecchia C; Gulie C; Franceschi S; Negri E Eur J Cancer; 1993; 29A(10):1445-9. PubMed ID: 8398274 [TBL] [Abstract][Full Text] [Related]
46. Mechanisms of thrombosis related to hormone therapy. Sandset PM; Høibraaten E; Eilertsen AL; Dahm A Thromb Res; 2009; 123 Suppl 2():S70-3. PubMed ID: 19217481 [TBL] [Abstract][Full Text] [Related]
47. Progestogen deficiency and endometrial cancer risk. Schindler AE Maturitas; 2009 Apr; 62(4):334-7. PubMed ID: 19231117 [TBL] [Abstract][Full Text] [Related]
48. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought. Speroff L Menopause; 2008; 15(2):393-400. PubMed ID: 17925662 [TBL] [Abstract][Full Text] [Related]
49. Postmenopausal hormone therapy and breast cancer. Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723 [TBL] [Abstract][Full Text] [Related]
50. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort. Rodriguez C; Spencer Feigelson H; Deka A; Patel AV; Jacobs EJ; Thun MJ; Calle EE Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):655-60. PubMed ID: 18349283 [TBL] [Abstract][Full Text] [Related]
54. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women. Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119 [TBL] [Abstract][Full Text] [Related]
55. Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy. Bitzer J; Kenemans P; Mueck AO; Maturitas; 2008 Mar; 59(3):209-18. PubMed ID: 18343056 [TBL] [Abstract][Full Text] [Related]
56. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk]. von Schoultz B Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143 [No Abstract] [Full Text] [Related]
57. Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study. Weber AM Obstet Gynecol; 1997 Oct; 90(4 Pt 1):641-2. PubMed ID: 9380334 [No Abstract] [Full Text] [Related]
58. Postmenopausal hormone therapy and risk of breast cancer. Chen FP Chang Gung Med J; 2009; 32(2):140-7. PubMed ID: 19403003 [TBL] [Abstract][Full Text] [Related]
59. Hormone replacement therapy and the risk of reproductive cancers. Swan SH J Psychosom Obstet Gynaecol; 1997 Jun; 18(2):165-74. PubMed ID: 9219113 [No Abstract] [Full Text] [Related]
60. An analysis of ovarian cancer in the Million Women Study. Neves-E-Castro M Gynecol Endocrinol; 2007 Jul; 23(7):410-3. PubMed ID: 17701773 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]